These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 2901849

  • 1. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
    Rao MS, Dwivedi RS, Subbarao V, Reddy JK.
    Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849
    [Abstract] [Full Text] [Related]

  • 2. Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator.
    Milano M, Reddy JK, Prasad JD, Rao MS.
    Cancer Lett; 1987 Dec; 38(1-2):65-71. PubMed ID: 2891433
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis.
    Yeldandi AV, Milano M, Subbarao V, Reddy JK, Rao MS.
    Cancer Lett; 1989 Sep 15; 47(1-2):21-7. PubMed ID: 2636030
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
    Makowska JM, Anders C, Goldfarb PS, Bonner F, Gibson GG.
    Biochem Pharmacol; 1990 Sep 01; 40(5):1083-93. PubMed ID: 2390105
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-induced hepatocarcinogenesis: levels of activating and detoxifying enzymes in hepatocellular carcinomas induced by ciprofibrate.
    Rao MS, Kokkinakis DM, Subbarao V, Reddy JK.
    Carcinogenesis; 1987 Jan 01; 8(1):19-23. PubMed ID: 3100085
    [Abstract] [Full Text] [Related]

  • 6. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis.
    Glauert HP, Clark TD.
    Cancer Lett; 1989 Feb 01; 44(2):95-100. PubMed ID: 2920376
    [Abstract] [Full Text] [Related]

  • 7. Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice.
    Budroe JD, Umemura T, Angeloff K, Williams GM.
    Toxicol Appl Pharmacol; 1992 Apr 01; 113(2):192-8. PubMed ID: 1561628
    [Abstract] [Full Text] [Related]

  • 8. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
    Wilson MW, Lay LT, Chow CK, Tai HH, Robertson LW, Glauert HP.
    Arch Toxicol; 1995 Apr 01; 69(7):491-7. PubMed ID: 8526745
    [Abstract] [Full Text] [Related]

  • 9. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats.
    Rao MS, Subbarao V, Reddy JK.
    Cancer Lett; 1986 Jul 01; 32(1):33-9. PubMed ID: 3742486
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
    Kasai H, Okada Y, Nishimura S, Rao MS, Reddy JK.
    Cancer Res; 1989 May 15; 49(10):2603-5. PubMed ID: 2713844
    [Abstract] [Full Text] [Related]

  • 14. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
    Awasthi YC, Singh SV, Goel SK, Reddy JK.
    Biochem Biophys Res Commun; 1984 Sep 28; 123(3):1012-8. PubMed ID: 6487318
    [Abstract] [Full Text] [Related]

  • 15. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator.
    Rao MS, Subbarao V.
    Cancer Lett; 1995 Nov 06; 97(2):185-8. PubMed ID: 7497461
    [Abstract] [Full Text] [Related]

  • 16. Species differences in the hepatic response to a potent peroxisome proliferator.
    Makowska JM, Bonner FW, Goldfarb PS, Gibson GG.
    Biochem Soc Trans; 1989 Dec 06; 17(6):1072-3. PubMed ID: 2628085
    [No Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS, Lalwani ND, Watanabe TK, Reddy JK.
    Cancer Res; 1984 Mar 06; 44(3):1072-6. PubMed ID: 6692393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK, Bartlett K, Sherratt HS, Agius L.
    Biochem J; 1988 Jul 15; 253(2):337-43. PubMed ID: 3178716
    [Abstract] [Full Text] [Related]

  • 20. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.
    Makowska JM, Bonner FW, Gibson GG.
    Arch Toxicol; 1991 Jul 15; 65(2):106-13. PubMed ID: 1905530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.